Recruiting A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States NCT07554521 Conditions Advanced Gastroesophageal Adenocarcinoma, Advanced Unresectable Gastric Adenocarcinoma, Carcinoma, +14 more Locations Los Angeles Cancer Network — Los Angeles, California, United States Bioresearch Partners Holding Hialeah Hospital — Hialeah, Florida, United States Florida Clinical Trials Group Plantation — Plantation, Florida, United States Florida Clinical Trials Group Tamarac — Tamarac, Florida, United States View more locations Show fewer locations Loading locations... View Trial Details
Active, Not Recruiting A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer NCT06251973 Conditions Adenocarcinoma Of Esophagus, Advanced Unresectable Gastric Adenocarcinoma, Digestive System Diseases, +22 more Locations Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey, United States Memorial Sloan Kettering Monmouth (Limited Protocol Activities) — Middletown, New Jersey, United States Memorial Sloan Kettering Bergen (Limited Protocol Activities) — Montvale, New Jersey, United States Memorial Sloan Kettering Suffolk-Commack (Limited protocol activities) — Commack, New York, United States View more locations Show fewer locations Loading locations... View Trial Details
